These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 20609130)

  • 1. Botulinum toxin A for treatment of allodynia of complex regional pain syndrome: a pilot study.
    Safarpour D; Salardini A; Richardson D; Jabbari B
    Pain Med; 2010 Sep; 11(9):1411-4. PubMed ID: 20609130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin A (Botox) for treatment of proximal myofascial pain in complex regional pain syndrome: two cases.
    Safarpour D; Jabbari B
    Pain Med; 2010 Sep; 11(9):1415-8. PubMed ID: 20735753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous botulinum toxin A for the treatment of refractory complex regional pain syndrome.
    Birthi P; Sloan P; Salles S
    PM R; 2012 Jun; 4(6):446-9. PubMed ID: 22732156
    [No Abstract]   [Full Text] [Related]  

  • 4. Intramuscular botulinum toxin in complex regional pain syndrome: case series and literature review.
    Kharkar S; Ambady P; Venkatesh Y; Schwartzman RJ
    Pain Physician; 2011; 14(5):419-24. PubMed ID: 21927045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin A does not alter capsaicin-induced pain perception in human skin.
    Schulte-Mattler WJ; Opatz O; Blersch W; May A; Bigalke H; Wohlfahrt K
    J Neurol Sci; 2007 Sep; 260(1-2):38-42. PubMed ID: 17481662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.
    Xiao L; Mackey S; Hui H; Xong D; Zhang Q; Zhang D
    Pain Med; 2010 Dec; 11(12):1827-33. PubMed ID: 21134121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lack of efficacy of different infusion rates of intrathecal baclofen in complex regional pain syndrome: a randomized, double-blind, crossover study.
    van der Plas AA; Marinus J; Eldabe S; Buchser E; van Hilten JJ
    Pain Med; 2011 Mar; 12(3):459-65. PubMed ID: 21332937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Botulinum toxin type A for the treatment of primary hyperhidrosis: a prospective study of 52 patients].
    Martí N; Ramón D; Gámez L; Reig I; García-Pérez MA; Alonso V; Jordá E
    Actas Dermosifiliogr; 2010 Sep; 101(7):614-21. PubMed ID: 20858387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of allodynia in patients with complex regional pain syndrome: A double-blind placebo-controlled trial of topical ketamine.
    Finch PM; Knudsen L; Drummond PD
    Pain; 2009 Nov; 146(1-2):18-25. PubMed ID: 19703730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H; Heinze A; Reichel G; Hefter H; Benecke R;
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of palmar hyperhidrosis with botulinum toxin type A: results of a pilot study based on a novel injective approach.
    Campanati A; Giuliodori K; Giuliano A; Martina E; Ganzetti G; Marconi B; Chiarici A; Offidani A
    Arch Dermatol Res; 2013 Oct; 305(8):691-7. PubMed ID: 23800969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin versus submandibular duct relocation for severe drooling.
    Scheffer AR; Erasmus C; VAN Hulst K; VAN Limbeek J; Rotteveel JJ; Jongerius PH; van den Hoogen FJ
    Dev Med Child Neurol; 2010 Nov; 52(11):1038-42. PubMed ID: 20561006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin for diabetic neuropathic pain: a randomized double-blind crossover trial.
    Yuan RY; Sheu JJ; Yu JM; Chen WT; Tseng IJ; Chang HH; Hu CJ
    Neurology; 2009 Apr; 72(17):1473-8. PubMed ID: 19246421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic block with botulinum toxin to treat complex regional pain syndrome.
    Carroll I; Clark JD; Mackey S
    Ann Neurol; 2009 Mar; 65(3):348-51. PubMed ID: 19334078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A induces direct analgesic effects in chronic neuropathic pain.
    Ranoux D; Attal N; Morain F; Bouhassira D
    Ann Neurol; 2008 Sep; 64(3):274-83. PubMed ID: 18546285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-allodynic efficacy of botulinum neurotoxin A in a model of neuropathic pain.
    Luvisetto S; Marinelli S; Cobianchi S; Pavone F
    Neuroscience; 2007 Mar; 145(1):1-4. PubMed ID: 17218063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum neurotoxin-A does not spread to distant muscles after intragastric injection: A double-blind single-fiber electromyography study.
    Osio M; Mailland E; Muscia F; Nascimbene C; Vanotti A; Bana C; Corsi F; Foschi D; Mariani C
    Muscle Nerve; 2010 Aug; 42(2):165-9. PubMed ID: 20564593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular pressure before and after botulinum toxin in chronic exertional compartment syndrome of the leg: a preliminary study.
    Isner-Horobeti ME; Dufour SP; Blaes C; Lecocq J
    Am J Sports Med; 2013 Nov; 41(11):2558-66. PubMed ID: 23969633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin for the treatment of menopausal hot flushes: a pilot study.
    Odo ME; Odo LM; Farias RV; Primavera RA; Leão L; Cucé LC; Juliano Y
    Dermatol Surg; 2011 Nov; 37(11):1579-83. PubMed ID: 21790852
    [No Abstract]   [Full Text] [Related]  

  • 20. Prophylactic botulinum type A toxin complex (Dysport®) for migraine without aura.
    Chankrachang S; Arayawichanont A; Poungvarin N; Nidhinandana S; Boonkongchuen P; Towanabut S; Sithinamsuwan P; Kongsaengdao S
    Headache; 2011 Jan; 51(1):52-63. PubMed ID: 21083558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.